中国常染色体显性遗传性肾小管间质性肾病患者的临床与遗传特征
该研究纳入北京大学第一医院2010至2024年符合KDIGO临床标准的70例ADTKD患者,采用全外显子组测序及PacBio长读长测序进行基因检测,并检测血浆和尿液尿调节蛋白水平。结果显示ADTKD-UMOD最常见(51%),其次为HNF1B(23%)、MUC1(20%)和REN(6%);尿调节蛋白对诊断ADTKD-UMOD具有较高准确性。
要点
- 中国ADTKD队列中UMOD变异最常见,占51%。
- 71%患者有慢性肾脏病家族史,HNF1B病例中50%为新发变异。
- 血浆和尿液尿调节蛋白可有效鉴别ADTKD-UMOD。
核心结论
- 该研究建立了中国首个ADTKD队列,揭示UMOD和HNF1B变异高发等独特遗传与临床特征。
- 尿液和血浆尿调节蛋白是诊断和监测ADTKD-UMOD的可靠生物标志物。
研究设计与样本
- 研究纳入2010至2024年北京大学第一医院符合KDIGO临床标准的70例ADTKD患者。
- 基因检测采用全外显子组测序,对符合临床标准但未发现致病变异者采用PacBio长读长测序。
- 检测血浆和尿液尿调节蛋白水平,并与IgA肾病和多囊肾病患者比较。
主要发现
- ADTKD-UMOD占51%,ADTKD-HNF1B占23%,ADTKD-MUC1占20%,ADTKD-REN占6%。
- 71%患者有慢性肾脏病家族史,ADTKD-HNF1B病例中50%为新发变异。
- 诊断时平均年龄32±11岁,平均eGFR为46±21 ml/min/1.73 m²。
- 尿调节蛋白鉴别ADTKD-UMOD的曲线下面积:血浆0.85,尿液0.86,联合0.93。
临床怎么用
- 在临床实践中可纳入尿调节蛋白检测,以改善ADTKD及相关肾脏疾病的早期诊断和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is recognized as a significant cause of genetic kidney disease. However, data from Asian populations remain limited. METHODS: We evaluated 70 patients meeting KDIGO clinical criteria for ADTKD at Peking University First Hospital between 2010 and 2024. Genetic testing was performed using whole-exome sequencing, with PacBio long-read sequencing employed for cases meeting clinical criteria but lacking identifiable causal variants. Plasma and urinary uromodulin levels were measured and compared between ADTKD, IgA nephropathy, and polycystic kidney disease patients. RESULTS: In this Chinese cohort of 70 ADTKD patients, ADTKD-UMOD was the most prevalent subtype, accounting for 51% of cases, followed by ADTKD-HNF1B (23%), ADTKD-MUC1 (20%), and ADTKD-REN (6%). A notable 71% of patients had a family history of chronic kidney disease, with de novo variants present in 50% of ADTKD-HNF1B cases. The mean age at diagnosis was 32 ± 11 years, and patients exhibited an average estimated glomerular filtration rate (eGFR) of 46 ± 21 ml/min/1.73 m². Importantly, uromodulin levels proved to be a highly effective biomarker, distinguishing ADTKD-UMOD from other subtypes and kidney diseases with impressive diagnostic accuracy, achieving area under the curve values of 0.85 for plasma, 0.86 for urine, and 0.93 when combined. CONCLUSION: This study establishes the first ADTKD cohort in China, revealing distinctive genetic and clinical features, including a high prevalence of UMOD and HNF1B variants. Urine and plasma uromodulin proved to be reliable biomarkers for diagnosing and monitoring ADTKD-UMOD. Incorporating uromodulin testing into clinical practice may improve early diagnosis and management of ADTKD and related kidney diseases.
引用
- Li MS, Jiang L, You RL, et al. Autosomal dominant tubulointerstitial kidney disease in Chinese patients. Nephrol Dial Transplant. 2026. PMID: 41143746. doi:10.1093/ndt/gfaf229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。